4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-039326
Options or other derivatives
- Director acquired 234,407 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sigal Charles Elliott Director | 2019-07-02 | Grant or award · Option to purchase Ordinary Shares | +234,407 | 234,407 | D: show line 1 in the form |
Loading xslF345X03/a4.xml…